Rohan Garje

26PUBLICATIONS
124CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 26, 2026
Clinical and Sociodemographic Determinants of Treatment Selection in Prostate Cancer: A Population-Based Study in the United States (2004-2022).

|Mar 12, 2026
Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.

Rana R McKay, Shayan S Nazari, Andrew Elliott

|Dec 05, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.

Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto

|Dec 03, 2025
Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen

|May 02, 2025
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.

Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi

|Jan 29, 2025
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell Carcinoma.

Yousef Zakharia, Ryan J Reis, Matthew R Kroll

Pageof 5

Frequent Collaborators

9 joint publications

Rana R McKay

6 joint publications

Tanya Dorff

6 joint publications

Clara Hwang

6 joint publications

Andrew J Armstrong